These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 24053618)
1. Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder. Kluth LA; Xylinas E; Rieken M; El Ghouayel M; Sun M; Karakiewicz PI; Lotan Y; Chun FK; Boorjian SA; Lee RK; Briganti A; RouprĂȘt M; Fisch M; Scherr DS; Shariat SF BJU Int; 2014 Mar; 113(3):393-8. PubMed ID: 24053618 [TBL] [Abstract][Full Text] [Related]
2. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study. Vetterlein MW; Gild P; Kluth LA; Seisen T; Gierth M; Fritsche HM; Burger M; Protzel C; Hakenberg OW; von Landenberg N; Roghmann F; Noldus J; Nuhn P; Pycha A; Rink M; Chun FK; May M; Fisch M; Aziz A; BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486 [TBL] [Abstract][Full Text] [Related]
3. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Linder BJ; Frank I; Cheville JC; Tollefson MK; Thompson RH; Tarrell RF; Thapa P; Boorjian SA Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883 [TBL] [Abstract][Full Text] [Related]
4. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy. Chromecki TF; Cha EK; Fajkovic H; Rink M; Ehdaie B; Svatek RS; Karakiewicz PI; Lotan Y; Tilki D; Bastian PJ; Daneshmand S; Kassouf W; Durand M; Novara G; Fritsche HM; Burger M; Izawa JI; Brisuda A; Babjuk M; Pummer K; Shariat SF BJU Int; 2013 Feb; 111(2):249-55. PubMed ID: 22727036 [TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy. Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005 [TBL] [Abstract][Full Text] [Related]
6. Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy. Rink M; Hansen J; Cha EK; Green DA; Babjuk M; Svatek RS; Xylinas E; Tagawa ST; Faison T; Novara G; Karakiewicz PI; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Comploj E; Tilki D; Bastian PJ; Chun FK; Dahlem R; Scherr DS; Shariat SF BJU Int; 2013 Jan; 111(1):74-84. PubMed ID: 22809039 [TBL] [Abstract][Full Text] [Related]
7. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854 [TBL] [Abstract][Full Text] [Related]
8. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. Xylinas E; Rink M; Robinson BD; Lotan Y; Babjuk M; Brisuda A; Green DA; Kluth LA; Pycha A; Fradet Y; Faison T; Lee RK; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126 [TBL] [Abstract][Full Text] [Related]
9. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma. Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245 [TBL] [Abstract][Full Text] [Related]
10. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503 [TBL] [Abstract][Full Text] [Related]
11. Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients. Mitra AP; Skinner EC; Schuckman AK; Quinn DI; Dorff TB; Daneshmand S Urol Oncol; 2014 Jan; 32(1):52.e1-9. PubMed ID: 24239476 [TBL] [Abstract][Full Text] [Related]
12. Restrictive transfusion in radical cystectomy is safe. Syan-Bhanvadia S; Drangsholt S; Shah S; Cai J; Miranda G; Djaladat H; Daneshmand S Urol Oncol; 2017 Aug; 35(8):528.e15-528.e21. PubMed ID: 28476526 [TBL] [Abstract][Full Text] [Related]
13. Predictors of cancer-specific mortality after disease recurrence following radical cystectomy. Rink M; Lee DJ; Kent M; Xylinas E; Fritsche HM; Babjuk M; Brisuda A; Hansen J; Green DA; Aziz A; Cha EK; Novara G; Chun FK; Lotan Y; Bastian PJ; Tilki D; Gontero P; Pycha A; Baniel J; Mano R; Ficarra V; Trinh QD; Tagawa ST; Karakiewicz PI; Scherr DS; Sjoberg DD; Shariat SF; BJU Int; 2013 Mar; 111(3 Pt B):E30-6. PubMed ID: 22938654 [TBL] [Abstract][Full Text] [Related]
14. The impact of perioperative blood transfusion on survival following radical cystectomy for urothelial carcinoma. Sadeghi N; Badalato GM; Hruby G; Kates M; McKiernan JM Can J Urol; 2012 Oct; 19(5):6443-9. PubMed ID: 23040626 [TBL] [Abstract][Full Text] [Related]
15. Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort. Soave A; Dahlem R; Hansen J; Weisbach L; Minner S; Engel O; Kluth LA; Chun FK; Shariat SF; Fisch M; Rink M Eur J Surg Oncol; 2015 Mar; 41(3):368-77. PubMed ID: 24674298 [TBL] [Abstract][Full Text] [Related]
16. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Rieken M; Schubert T; Xylinas E; Kluth L; RouprĂȘt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF; Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094 [TBL] [Abstract][Full Text] [Related]
17. Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy. da Silva RD; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Chade D; Guglielmetti GB; Pycha A; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Zerbib M; Scherr DS; Shariat SF J Urol; 2013 Aug; 190(2):487-92. PubMed ID: 23395802 [TBL] [Abstract][Full Text] [Related]
18. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy. Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623 [TBL] [Abstract][Full Text] [Related]
19. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy. Mitra AP; Alemozaffar M; Harris BN; Schuckman AK; Skinner EC; Daneshmand S Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479 [TBL] [Abstract][Full Text] [Related]
20. The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy. Soave A; John LM; Dahlem R; Minner S; Engel O; Schmidt S; Kluth LA; Fisch M; Rink M Urology; 2015 Jul; 86(1):92-8. PubMed ID: 26051839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]